Background illustration for clinical trials search

Paid Clinical Trials Fort Worth

Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

for
Triple Negative Breast Cancer, Breast Cancer,
Location: Dallas TX, Oklahoma City OK, Houston TX, Nashville TN,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05377996

Phase 1, Phase 2, Recruiting

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: Dallas TX, Mesquite TX, Longview TX, Round Rock TX,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07752979

Phase 2, Recruiting

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

for
Apnea, Sleep Disorders, Overweight and/or Obesity
Location: Dallas TX, Little Rock AR, Cullman AL, Maplewood MN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07823608

Phase 3, Recruiting

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial

for
Radiation Protection
Location: Plano TX
Sponsor: Baylor Research Institute

Sex: All

Age: 0+

Code: NCT07467720

Recruiting

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Dallas TX, Norman OK, Oklahoma City OK, Tomball TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351058

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Hydrus® Microstent New Enrollment Post-Approval Study

for
Primary Open Angle Glaucoma
Location: Dallas TX, Austin TX, Overland Park KS, El Paso TX,
Sponsor: Alcon Research

Sex: All

Age: 45+

Code: NCT04553523

Recruiting

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

for
Influenza
Location: Dallas TX, Plano TX, Edmond OK, Tulsa OK, Houston TX,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 12+

Code: NCT07159763

Phase 3, Recruiting

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

for
Geographic Atrophy (GA),
Location: Southlake TX, Austin TX, The Woodlands TX, Katy TX,
Sponsor: ONL Therapeutics

Sex: All

Age: 55+

Code: NCT06659445

Phase 2, Recruiting

Minima Stent System Post- Approval Study (PAS)

for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Dallas TX, Austin TX, Saint Louis MI, Aurora CO,
Sponsor: Renata Medical

Sex: All

Age: 0+

Code: NCT06828770

Recruiting

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

for
Prosthetic-joint Infection
Location: Dallas TX, Oklahoma City OK, Shreveport LA, Katy TX,
Sponsor: Peptilogics

Sex: All

Age: 18 - 70+

Code: NCT07214311

Phase 2, Phase 3, Recruiting

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Dallas TX, Kansas City KS, Memphis TN, St Louis MO,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07358078

Recruiting

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

for
Advanced Hepatocellular Carcinoma,
Location: Dallas TX, San Antonio TX, Houston TX, Atlanta GA,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06600321

Phase 1, Recruiting

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Dallas TX, San Antonio TX, Denver CO, Nashville TN,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07372625

Phase 1, Recruiting

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer,
Location: Dallas TX, St Louis MO, Nashville TN, Greenville SC,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18+

Code: NCT07545811

Phase 1, Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

for
Acute Myeloid Leukemia (AML)
Location: Dallas TX, Austin TX, San Antonio TX, Houston TX,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07007312

Phase 3, Recruiting

Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

for
Advanced HR+/HER2- Breast Cancer
Location: Dallas TX, Kansas City KS, Toronto, New Haven CT
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07604571

Phase 1, Recruiting

Alleviant ALLAY-HF Study

for
Heart Failure
Location: Dallas TX, Plano TX, Waco TX, Abilene TX, Austin TX,
Sponsor: Alleviant Medical, Inc.

Sex: All

Age: 40+

Code: NCT05685303

Recruiting

Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

for
HIV-1-infection
Location: Fort Worth TX, Dallas TX, Bellaire TX, Kansas City MO,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07708727

Phase 2, Phase 3, Recruiting

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

for
Neoplasm Metastasis, Non-Small Cell Lung Cancer
Location: Dallas TX, Houston TX, Birmingham AL, Nashville TN,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT04886804

Phase 1, Recruiting

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: Dallas TX, Baton Rouge LA, St Louis MO,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07170917

Phase 2, Recruiting